EGFR and breast carcinoma: Another example of the use of EV in therapy was demonstrated by Ohno et al. [76], who engineered cells to obtain EV expressing the GE11 peptide fused with the transmembrane domain of platelet-derived growth factor receptor and which showed an efficient in vivo delivery of miRNA to breast cancer cells bearing the epidermal growth factor receptor (EGFR).